RGA Filings — Reinsurance Group of America Inc - FilingSpy
RGA
Reinsurance Group of America Inc
A maker of life and health reinsurance, RGA backs other insurers by taking on some of the risk they carry on individual and group life, disability, long-term care, and retirement policies, working with clients across dozens of countries. It grew out of General American Life Insurance, starting as that company's reinsurance arm in 1973 before going public on its own in 1993. The name RGA is simply short for Reinsurance Group of America, though its reach now spans the globe.
RGA Q2 net income more than doubles to $462M as Equitable deal, favorable claims, and investment income lift operating margin to 9.1%.
Underwriting turned sharply favorable across every . rose 18.5% to $6.6 billion and widened 3.0 points to 9.1% as claims ran below expectations, the Equitable transaction added $39 million, and net investment income climbed $456 million. The business is earning more from both insurance and investments at the same time.
Key takeaways
rose 156.7% to $462 million, or $7.01 per diluted share, as a $264 million increase in pre-tax income combined with a drop in the to 23.4% from 47.0% a year ago when uncertain tax positions were resolved unfavorably.
Favorable claims experience across all operating segments reduced claims and policy benefits relative to expectations, boosting Traditional results and lifting the consolidated to 9.1% from 6.1% a year ago.
Section summaries
Management's Discussion and Analysis
RGA Q2 FY2026 net income rose to $462M driven by Equitable transaction, favorable claims, and higher investment income.
⌄
Consolidated available to shareholders increased $282M to $462M for Q2 2026, with income before tax up $264M to $605M.
The Equitable Holdings transaction, closed in July 2025, contributed $39 million to pre-tax income in Q2 and $78 million in the first half of 2026, primarily in the U.S. Financial Solutions .
Net investment income rose $456 million to $1.9 billion, driven by growth in the invested asset base, higher new money rates, and increased variable investment income from partnerships.
Investment-related losses widened by $32 million to $76 million, largely from realized losses on portfolio repositioning and fair value declines in limited partnerships, partially offsetting the investment income gain.
was negative $0.5 billion, an improvement from negative $0.8 billion a year ago, while cash and equivalents stood at $5.3 billion and declined 6.5% sequentially to $5.7 billion.
What changed
The U.S. and Latin America Traditional 's adjusted , which collapsed to $4 million in Q2 2025 on a $140 million remeasurement loss and higher claims, recovered sharply as claims ran favorably and no new remeasurement loss was reported.
Investment-related losses, flagged last quarter after widening to $170 million in Q1 2026, narrowed to $76 million in Q2, suggesting the Q1 spike was not the start of a new repositioning phase.
The Equitable transaction's quarterly contribution held steady at $39 million, matching Q1 2026, indicating a stable run-rate rather than the ramp-up some had anticipated.
remained negative for the quarter, extending the pattern of negative cash generation outside of Q4, though the $0.5 billion outflow was the smallest negative reading since Q2 2025.
What to watch
Whether the favorable claims experience across all segments is a one-quarter event or the start of a sustained trend, and what it implies for the full-year loss ratio.
The trajectory of the , which fell to 23.4% in Q2 after spiking to 47.0% a year ago on uncertain tax positions — whether the lower rate is the new normal.
Whether can finally turn positive in Q3, or if the pattern of negative quarterly cash generation outside of Q4 persists for another year.
The U.K. mortality assumption that drove a $222 million charge in the 2025 annual review — whether it resurfaces in the 2026 review or proves to be a one-time reset.
The Equitable Holdings transaction, closed July 2025, contributed $39M to pre-tax income in Q2 and $78M in H1 2026, primarily in U.S. Financial Solutions.
Favorable claims experience across all operating segments reduced claims and policy benefits relative to expectations, boosting Traditional results.
Net investment income rose $456M in Q2, driven by growth in invested assets, higher new money rates, and increased variable investment income from partnerships.
Investment-related losses increased $32M to $76M in Q2, largely from realized losses on portfolio repositioning and fair value declines in limited partnerships.
The fell to 23.4% in Q2 2026 from 47.0% a year ago, primarily due to the resolution of uncertain tax positions in the prior period.
Quantitative and Qualitative Disclosures About Market Risk
Market risk is the risk of fluctuations in the value of financial instruments as a result of absolute or relative changes in interest rates, foreign currency exchange rates, equity prices or commodity prices. To varying degrees, the Company products and services, and the investm…
⌄
Market risk is the risk of fluctuations in the value of financial instruments as a result of absolute or relative changes in interest rates, foreign currency exchange rates, equity prices or commodity prices. To varying degrees, the Company products and services, and the investment activities supporting them, generate exposure to market risk. The market risk incurred, and the Company’s strategies for managing this risk, vary by product. As of June 30, 2026, there have been no material changes in the Company’s economic exposure to market risk or the Company’s Enterprise Risk Management function from December 31, 2025, a description of which may be found in its Annual Report on Form 10-K, for the year ended December 31, 2025, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” filed with the Securities and Exchange Commission.
The Company is subject to litigation and regulatory investigations or actions from time to time. Based on current knowledge, management does not believe that loss contingencies arising from pending legal, regulatory and governmental matters will have a material adverse effect on…
⌄
The Company is subject to litigation and regulatory investigations or actions from time to time. Based on current knowledge, management does not believe that loss contingencies arising from pending legal, regulatory and governmental matters will have a material adverse effect on the financial condition, results of operations or cash flows of the Company. However, in light of the inherent uncertainties involved in future or pending legal, regulatory and governmental matters, some of which are beyond the Company’s control, and indeterminate or potentially substantial amount of damages sought in any such matters, an adverse outcome could be material to the Company’s financial condition, results of operations or cash flows for any particular reporting period. A legal reserve is established when the Company is notified of an arbitration demand, litigation or regulatory action or is notified that an arbitration demand, litigation or regulatory action is imminent, it is probable that the Company will incur a loss as a result and the amount of the probable loss is reasonably capable of being estimated.